Autoimmune encephalitis mediated by antibodies against the N-Nethyl-N-Aspartate receptor: report of four cases in Peru

Autoimmune encephalitis with antibodies against the N-methyl-D-aspartate receptor (anti-NMDAR) is a disorder mediated by antibodies against neural surface antigens, whose early diagnosis and timely treatment improve the prognosis of the disease. Four cases with the definitive diagnosis of autoimmune...

Full description

Saved in:
Bibliographic Details
Published inRevista peruana de medicina experimental y salud pública Vol. 36; no. 1; p. 138
Main Authors Palomino-Lescano, Henry, Segura-Chávez, Darwin, Quispe-Orozco, Darko, Castro-Suarez, Sheila, De la Cruz, Walter, Zapata-Luyo, Willy, Delgado-Ríos, José, Cam, Juan, Alvarado-Morales, Marcela, Paredes-Carcasi, Lippmann, Cornejo-Herrera, Iván, Meza-Vega, María
Format Journal Article
LanguageSpanish
Published Peru 01.01.2019
Subjects
Adolescent
Autoantibodies - immunology
Encephalitis - immunology
Female
Hashimoto Disease - immunology
Humans
Male
Middle Aged
Peru
Receptors, N-Methyl-D-Aspartate - immunology
Young Adult
Peru
Online AccessGet full text

Cover

More Information
Summary:Autoimmune encephalitis with antibodies against the N-methyl-D-aspartate receptor (anti-NMDAR) is a disorder mediated by antibodies against neural surface antigens, whose early diagnosis and timely treatment improve the prognosis of the disease. Four cases with the definitive diagnosis of autoimmune encephalitis by anti-NMDAR are presented, treated at the National Institute of Neurological Sciences in Lima-Peru. All patients had epileptic seizures and three cases developed a refractory epileptic state. In addition, three patients presented neuropsychiatric alterations, dyskinesias, and dysautonomia. Two cases required ventilatory support. All presented an abnormal electroencephalogram; two cases had pleocytosis in cerebrospinal fluid, and only one showed brain abnormalities on MRI. Regarding treatment, all patients received methylprednisolone immunotherapy and only two of them required plasma exchange for an ineffective response to corticosteroid treatment. After 12 months of hospital discharge, three patients were free of epileptic seizures and only one case did not achieve functional independence. These cases show that anti-NMDAR encephalitis is a treatable condition and its early recognition together with appropriate treatment (immunotherapy/plasmapheresis) are essential for a favorable evolution.
ISSN:1726-4642